antibodies or antibody, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, antibodies or antibody

Aagaard BD, Heyworth MF, Oesterle AL, Jones AL, Way LW 1996 Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis. Gut 39: 136-140. *
Aamir IS, Tauheed S, Majeed F, Atif A 2008 Serum antithyroid antibodies in female patients with chronic urticaria. J. Coll. Physicians Surg. Pak. 18: 493-497.
Aarli JA, Romi F, Skeie GO, Gilhus NE 2003 Myasthenia gravis in individuals over 40. Ann. N. Y. Acad. Sci. 998: 424-431.
Aarnisalo J, Treszl A, Svec P, Marttila J, Oling V, Simell O, Knip M, Korner A, Madacsy L, Vasarhelyi B, Ilonen J, Hermann R 2008 Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J. Autoimmun. 31: 13-21.
Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J 2008 Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia 51: 769-772. *
Abad E, Tural C, Mirapeix E, Cuxart A 1997 Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. J. Autoimmun. 10: 175-180. *
Abadia-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, Yagita H, Sharpe A, Bhan AK, Terhorst C 2006 CD48 controls T cell and antigen-presenting cell functions in experimental colitis. Gastroenterology 130: 424-434. *
Abahusain MA, Al-Nahedh NN 2002 The biochemical status of vitamin A and alpha-tocopherol during different stages of renal disease and its relationship to diabetes. Saudi J. Kidney Dis. Transpl. 13: 18-23.
Abbasciano V, Trevisani L, Di Todaro F, Guglielmini C, Marzola A, Sartori S, Salemi A 2006 Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. An early case. Recenti. Prog. Med. 97: 28-31.
Abbasi AM, Chester KA, MacPherson AJ, Boxer GM, Begent RH, Malcolm AD 1992 Localization of CEA messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas. J. Pathol. 168: 405-411.
Abbasi SY, Milhem M, Zaru L 2008 A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura. Ann. Hematol. 87: 459-462.
Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, McHugh N, du Bois RM, Welsh KI 2006 A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. Int. J. Immunogenet. 33: 155-161. *
Abdel Rahman H, Abdul Wahab A, Abdel Rahman MO, Mostafa OA 2006 Faecal elastase-1 concentration in cystic fibrosis patients with CFTR I1234V mutation. Acta Paediatr. 95: 1066-1069. *
Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M 2006 Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin. Exp. Immunol. 145: 63-70. *
Abdou NI, Kullman GJ, Hoffman GS, Sharp GC, Specks U, McDonald T, Garrity J, Goeken JA, Allen NB 2002 Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J. Rheumatol. 29: 309-316.
Abdul-Aziz K, Faizal AA 2005 Serological diagnosis of autoimmune hepatobiliary diseases. Saudi Med. J. 26: 1875-1881.
Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG 2008 Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum. 58: 2196-2205. *
Abe K, Ohira H, Kobayashi H, Saito H, Takahashi A, Rai T, Kanno Y, Monoe K, Watanabe H, Irisawa A, Sato Y 2007 Breakthrough of immune self-tolerance to calreticulin induced by CpG-oligodeoxynucleotides as adjuvant. Fukushima J. Med. Sci. 53: 95-108.
Abe K, Saito H, Takahashi A, Rai T, Takiguchi J, Kanno Y, Monoe K, Ohira H 2007 A case of acute hepatitis associated with Basedow's disease. Nippon Shokakibyo Gakkai Zasshi 104: 52-56.
Abe M 2006 Complement activation and inflammation. Rinsho Byori 54: 744-756.
Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto K, Horiike N, Onji M 2003 Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern. Med. 42: 48-52. *
Abe M, Onji M, Kawai-Ninomiya K, Michitaka K, Matsuura B, Hiasa Y, Horiike N 2007 Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 5: 255-258.
Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y 2004 Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 40: 414-423. *
Abe T, Takeuchi T, Miyasaka N, Hashimoto H, Kondo H, Ichikawa Y, Nagaya I 2006 A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. J. Rheumatol. 33: 37-44.
Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H, Sakamaki H, Kawasaki E, Awata T, Yamaguchi Y, Eguchi K 1999 CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res. Clin. Pract. 46: 169-175.
Abedi MR, Hammarstrom L, Broome U, Angelin B, Smith CI, Christensson B 1996 Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC). Clin. Exp. Immunol. 105: 266-273. *
Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, Depierre JW, Hassan M 2005 Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice. Clin. Exp. Immunol. 141: 238-247. *
Abel B, Kurrer M, Shamshiev A, Marty RR, Eriksson U, Gunthert U, Kopf M 2006 The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis. Eur. J. Immunol. 36: 494-499. *
Abeles AM, Pillinger MH 2006 The role of the synovial fibroblast in rheumatoid arthritis - cartilage destruction and the regulation of matrix metalloproteinases. Bull. Hosp. Jt. Dis. 64: 20-24.
Abiru N, Kawasaki E, Eguch K 2002 Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab. Res. Rev. 18: 357-366. *
Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Caspi D, George J 2006 Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci. 79: 2364-2369. *
Abo SM, Debari VA 2007 Laboratory evaluation of the antiphospholipid syndrome. Ann. Clin. Lab. Sci. 37: 3-14.
Abo T, Kawamura T, Watanabe H 2005 Immunologic states of autoimmune diseases. Immunol. Res. 33: 23-34.
Abo T, Ohteki T, Seki S, Koyamada N, Yoshikai Y, Masuda T, Rikiishi H, Kumagai K 1991 The appearance of T cells bearing self-reactive T cell receptor in the livers of mice injected with bacteria. J. Exp. Med. 174: 417-424.
Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, Kuziel WA, Koni PA, Gurish MF 2005 Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105: 4308-4313. *
Aboul-Enein F, Weiser P, Hoftberger R, Lassmann H, Bradl M 2006 Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol. (Berl.) 111: 539-547.
Abourazzak FE, Guggenbuhl P, Perdriger A, Meadeb J, Gando-Cocley N, Chevrant-Breton J, Hajjaj-Hassouni N, Chales G 2008 Cutaneous lupus induced by etanercept in rheumatoid arthritis. Rev. Med. Interne. 29: 744-747.
Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner HL 2008 In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J. Autoimmun. 30: 21-28. *
Abrams JA, Brar P, Diamond B, Rotterdam H, Green PH 2006 Utility in clinical practice of immunoglobulin A anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin. Gastroenterol. Hepatol. 4: 726-730.
Abrams SI 2004 Role of anti-CTLA-4 therapies in the treatment of cancer. Curr. Opin. Mol. Ther. 6: 71-77.
Abramson SB, Amin A 2002 Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 41: 972-980. *
Abrass CK, Border WA, Hepner G 1980 Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin. Exp. Immunol. 40: 292-298. *
Abreu MT 2002 The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489.
Abreu MT, Yang H 2004 Is genetic testing in IBD ready for prime time? Am. J. Gastroenterol. 99: 316-318. *
Abu Romeh IS, Chhatriwalla AK, Atik FA, Bhatt DL, Navia JL 2007 Myocardial infarction secondary to a coronary ostial thrombus in antiphospholipid syndrome. Ann. Thorac. Surg. 83: 1170-1171.
Abu-Zekry M, Kryszak D, Diab M, Catassi C, Fasano A 2008 Prevalence of celiac disease in Egyptian children disputes the East-West agriculture-dependent spread of the disease. J. Pediatr. Gastroenterol. Nutr. 47: 136-140.
Accomando S, Cataldo F 2004 The global village of celiac disease. Dig. Liver Dis. 36: 492-498.
Achkar JP, Barmada MM, Duerr RH 2002 Perinuclear neutrophil antibodies are not markers for genetic susceptibility or indicators of genetic heterogeneity in familial ulcerative colitis. Am. J. Gastroenterol. 97: 2343-2349. *
Achord JL, Gunn CH Jr, Jackson JF 1982 Regional enteritis and HLA concordance in multiple siblings. Dig. Dis. Sci. 27: 330-332.
Ackerman LS 2006 Sex hormones and the genesis of autoimmunity. Arch. Dermatol. 142: 371-376. *
Acuna OM, Athannassaki I, Paysse EA 2007 Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease. Trans. Am. Ophthalmol. Soc. 105: 146-151. *
Adachi T, Toishi T, Takashima E, Hara H 2006 Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro. Biol. Pharm. Bull. 29: 2095-2098. *
Adachi Y, Yoshio-Hoshino N, Nishimoto N 2008 The blockade of IL-6 signaling in rational drug design. Curr. Pharm. Des. 14: 1217-1224.
Adam AC, Grohe C, Stier S, Gattenlohner S, Balta Z, Buttner R, Gutgemann I 2007 Hodgkin's lymphoma in a patient with Jo-1 syndrome. Virchows Arch. 451: 101-104. *
Adami P, Berrez JM, Latruffe N 1991 Mitochondrial pyruvate dehydrogenase complex subunits as autoantigens in human primary biliary cirrhosis. Biochem. Int. 23: 429-437.
Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, Hagerty D, Townsend R, Hollenbaugh D, Pearson TC, Larsen CP 2005 Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J. Immunol. 174: 542-550. *
Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, Kupper TS 2004 Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J. Am. Acad. Dermatol. 51: 660-662.
Adams DD, Knight JG, Manning P, Smith G 2005 An informative case of Graves' disease with implications for schizophrenia. J. Clin. Lab. Immunol. 53: 13-25.
Adams EJ, Chien YH, Garcia KC 2005 Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science 308: 227-231. *
Adams LA, Lindor KD, Angulo P 2004 The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 99: 1316-1320. *
Adams RJ, Heazlewood SP, Gilshenan KS, O'Brien M, McGuckin MA, Florin TH 2008 IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin. Am. J. Gastroenterol. 103: 386-396. *
Adarichev VA, Vegvari A, Szabo Z, Kis-Toth K, Mikecz K, Glant TT 2008 Congenic strains displaying similar clinical phenotype of arthritis represent different immunologic models of inflammation. Genes Immun. Jul 24 [Epub ahead of print].
Adhami E 2004 Calculating the etiology of systemic lupus erythematosus. Med. Hypotheses 62: 237-246.
Adler EM 2004 Focus issue - tailoring the immune response. Sci. STKE 241: EG9. *
Adler EM 2007 IL-2 antagonizes Th17 differentiation. Sci. STKE 379: tw103.
Adler G 2005 The posttranslational modification of thyrotropin receptor and thyroid diseases. Endokrynol. Pol. 56: 72-77.
Adrych KJ, Marek IE, Kryszewski AJ 2006 Adults celiac disease - the tip of the iceberg. Wiad. Lek. 59: 359-363.
Aebi C, Theiler F, Aebischer CC, Schoeni MH 2000 Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization. Pediatr. Infect. Dis. J. 19: 207-212.
Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS, Adams DH 2001 CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J. 15: 2345-2354. *
Afford SC, Randhawa S, Eliopoulos AG, Hubscher SG, Young LS, Adams DH 1999 CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J. Exp. Med. 189: 441-446. *
Agardh D 2007 Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin. Gastroenterol. Hepatol. 5: 1276-1281.
Agardh D, Dahlbom I, Daniels T, Lorinc E, Ivarsson SA, Lernmark A, Hansson T 2005 Autoantibodies against soluble and immobilized human recombinant tissue transglutaminase in children with celiac disease. J. Pediatr. Gastroenterol. Nutr. 41: 322-327. *
Agardh D, Lynch K, Brundin C, Ivarsson SA, Lernmark A, Cilio CM 2006 Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease. Clin. Exp. Immunol. 144: 67-75. *
Agardh D, Roth B, Lernmark A, Stenberg P 2005 Calcium activation of tissue transglutaminase in radioligand binding and enzyme-linked autoantibody immunoassays in childhood celiac disease. Clin. Chim. Acta 358: 95-103. *
Agarwal B 2008 Biological therapy for pediatric malignancy: current perspectives. Indian J. Pediatr. 75: 839-844.
Agarwal K, Czaja AJ, Jones DE, Donaldson PT 2000 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31: 49-53. *
Agarwal K, Jones DE, Watt FE, Burt AD, Floreani A, Bassendine MF 2002 Familial primary biliary cirrhosis and autoimmune cholangitis. Dig. Liver Dis. 34: 50-52.
Agarwal N, Puri AS, Grover R 2007 Non-diarrheal celiac disease: a report of 31 cases from Northern India. Indian J. Gastroenterol. 26: 122-126. *
Agate L, Mariotti S, Elisei R, Mossa P, Pacini F, Molinaro E, Grasso L, Masserini L, Mokhort T, Vorontsova T, Arynchyn A, Tronko MD, Tsyb A, Feldt-Rasmussen U, Juul A, Pinchera A 2008 Thyroid autoantibodies (ATA) and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease. J. Clin. Endocrinol. Metab. 93: 2729-2736. *
Agematsu K, Futatani T, Hokibara S, Kobayashi N, Takamoto M, Tsukada S, Suzuki H, Koyasu S, Miyawaki T, Sugane K, Komiyama A, Ochs HD 2002 Absence of memory B cells in patients with common variable immunodeficiency. Clin. Immunol. 103: 34-42.
Aggarwal A, Catlett JP 2002 Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura. South. Med. J. 95: 1209-1212.
Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H 2006 TNF blockade: an inflammatory issue. Ernst Schering Res. Found. Workshop 56: 161-186.
Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, Parvaneh N, Abolhassani H, Pourpak Z, Moin M 2008 IgA deficiency: correlation between clinical and immunological phenotypes. J. Clin. Immunol. Aug 6 [Epub ahead of print]. *
Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Nikzad M, Movahedi M, Gharagozlou M, Atarod L, Ahmadi Afshar A, Bazargan N, Abolmaali K, Mahmoudi M 2003 Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency. Iran. J. Allergy Asthma Immunol. 2: 121-126.
Aghamohammadi A, Farhoudi A, Nikzad M, Moin M, Pourpak Z, Rezaei N, Gharagozlou M, Movahedi M, Atarod L, Afshar AA, Bazargan N, Hosseinpoor AR 2004 Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann. Allergy Asthma Immunol. 92: 60-64.
Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, Hammarstrom L 2008 Progression of selective IgA deficiency to common variable immunodeficiency. Int. Arch. Allergy Immunol. 147: 87-92.
Aghamohammadi A, Sedighipour L, Saeed SE, Kouhkan A, Heydarzadeh M, Pourpak Z 2008 Alterations in humoral immunity in relatives of patients with common variable immunodeficiency. J. Investig. Allergol. Clin. Immunol. 18: 266-271.
Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sorensen ES 2007 Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scand. J. Immunol. 65: 453-460. *
Agoston-Coldea L, Fodor D, Pais R, Rusu ML, Georgiu C 2002 Autoimmune cholangitis in patients with primary Sjogren's syndrome. A case report. Rom. J. Gastroenterol. 11: 321-324.
Agraou B, Le Tourneau T, Agraou H, Leroy F, Asseman P, Dujardin JJ 1998 Primary biliary cirrhosis associated with pericardial effusion. Ann. Cardiol. Angeiol. (Paris) 47: 576-578.
Agrawal S, Misra R, Aggarwal A 2007 Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin. Rheumatol. 26: 201-204. *
Aguilar F, Nunez-Roldan A, Torres B, Wichmann I, Sanchez-Roman J, Gonzalez-Escribano MF 2003 Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30: 1770-1774.
Aguilera I, Sousa JM, Gavilan F, Bernardos A, Wichmann I, Nunez-Roldan A 2004 Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl. 10: 1166-1172. *
Aguilera I, Wichmann I, Sousa JM, Bernardos A, Franco E, Garcia-Lozano JR, Nunez-Roldan A 2001 Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin. Exp. Immunol. 126: 535-539. *
Aguilera O, Pena C, Garcia JM, Larriba MJ, Ordonez-Moran P, Navarro D, Barbachano A, de Silanes IL, Ballestar E, Fraga MF, Esteller M, Gamallo C, Bonilla F, Gonzalez-Sancho JM, Munoz A 2007 The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28: 1877-1884. *
Aguillon JC, Contreras J, Dotte A, Cruzat A, Catalan D, Salazar L, Molina MC, Guerrero J, Lopez M, Soto L, Salazar-Onfray F, Cuchacovich M 2003 New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies. Rev. Med. Chil. 131: 1445-1453.
Aguirre S, Silber AM, Brito ME, Ribone ME, Lagier CM, Marcipar IS 2006 Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection. J. Clin. Microbiol. 44: 3768-3774. *
Ahangari G, Naderimanesh H, Hossein-Nezhad A, Zouali M 2008 A novel tissue engineering-based assay for immunological infertility. Scand. J. Immunol. 68: 463-468. *
Ahlemann M, Schmitt B, Stieber P, Gires O, Lang S, Zeidler R 2006 Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations. Anticancer Res. 26: 783-789.
Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP 2004 Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP). Am. J. Hematol. 77: 171-176. *
Ahmad R, Qureshi HY, El Mabrouk M, Sylvester J, Ahmad M Dr, Zafarullah M 2007 Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma. Ann. Rheum. Dis. 66: 782-789. *
Ahmad Y, Shelmerdine J, Bodill H, Lunt M, Pattrick MG, Teh LS, Bernstein RM, Walker MG, Bruce IN 2007 Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford) 46: 983-988. *
Ahmadi KR, Lanchbury JS, Reed P, Chiano M, Thompson D, Galley M, Line A, Lank E, Wong HJ, Strachan D, Spector TD 2003 Novel association suggests multiple independent QTLs within chromosome 5q21-33 region control variation in total humans IgE levels. Genes Immun. 4: 289-297. *
Ahmed B, Tschen JA, Cohen PR, Zaki MH, Rady PL, Tyring SK, Corringham RE, Kurzrock R 2007 Cutaneous Castleman's disease responds to anti interleukin-6 treatment. Mol. Cancer Ther. 6: 2386-2390.
Ahmed MM, Mubashir E, Wolf RE, Hayat S, Hall V, Shi R, Berney SM 2006 Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis. South. Med. J. 99: 1209-1215.
Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, Takeuchi T, Hara T 2001 Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 40: 662-667. *
Ahmed SS, Tan FK 2003 Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations. Curr. Opin. Rheumatol. 15: 766-771.
Ahn BK, Kim SC 2004 Pyodermatitis-pyostomatitis vegetans with circulating autoantibodies to bullous pemphigoid antigen 230. J. Am. Acad. Dermatol. 50: 785-788.
Ahn ER, Lander G, Bidot CJ, Jy W, Ahn YS 2005 Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy. Am. J. Hematol. 78: 127-129. *
Ahn JS, Krishnadas DK, Agrawal B 2007 Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Int. Immunol. 19: 227-237.
Ahn S, Lee G, Yang SJ, Lee D, Lee S, Shin HS, Kim MC, Lee KN, Palmer DC, Theoret MR, Jenkinson EJ, Anderson G, Restifo NP, Kim MG 2008 TSCOT (+) thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentation. PLoS Biol. 6: e191. *
Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D 2000 p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J. Hepatobiliary Pancreat. Surg. 7: 426-431.
Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ 2007 Depletion of B cells in murine lupus: efficacy and resistance. J. Immunol. 179: 3351-3361. *
Aichele D, Schnare M, Saake M, Rollinghoff M, Gessner A 2006 Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect. Immun. 74: 4708-4714. *
Aigner E, Schmid I, Osterreicher CH, Zwerina J, Schett G, Strasser M, Niksic F, Hohla F, Ramsauer T, Dorn U, Patsch W, Datz C 2007 Contribution of anti-cyclic citrullinated peptide and rheumatoid factors for the diagnosis of arthropathy in patients with hereditary hemochromatosis. Ann. Rheum. Dis. 66: 1249-1251. *
Ainsworth MA, Bendtzen K, Brynskov J 2008 Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. Am. J. Gastroenterol. 103: 944-948. *
Ainsworth MA, Brynskov J 2007 Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis. Ugeskr. Laeger. 169: 789-791.
Aires da Silva F, Corte-Real S, Goncalves J 2008 Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs. BioDrugs 22: 301-314.
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB 2004 Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. 99: 432-441. *
Aisenberg J, Wagreich J, Shim J, Almer S, Peen E, Heimann T, Gelernt IM, Greenstein A, Rubin P, Harpaz N, et al 1995 Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study. Dig. Dis. Sci. 40: 1866-1872.
Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JBS, Alexander G, Kenna JG, Caldwell J, Day CP 2004 Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39: 1430-1440. *
Aitola P, Miettinen A, Mattila A, Matikainen M, Soppi E 1995 Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J. Clin. Pathol. 48: 645-647. *
Aittoniemi J, Turpeinen H, Tiittanen M, Knip M, Simell O, Ilonen J, Vaarala O 2008 Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children. Hum. Immunol. 69: 108-111.
Ajith C, Gupta S, Kanwar AJ 2006 Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in alopecia areata and factors influencing the outcome. J. Drugs Dermatol. 5: 262-266.
Akagawa M, Ito S, Toyoda K, Ishii Y, Tatsuda E, Shibata T, Yamaguchi S, Kawai Y, Ishino K, Kishi Y, Adachi T, Tsubata T, Takasaki Y, Hattori N, Matsuda T, Uchida K 2006 Bispecific Abs against modified protein and DNA with oxidized lipids. Proc. Natl. Acad. Sci. U.S.A. 103: 6160-6165. *
Akahoshi K, Miyata Y, Hashimoto M, Koga S, Chijiiwa Y, Misawa T, Suematsu E, Nishimura J, Nawata H 1992 A case of combined primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia. Gastroenterol. Jpn. 27: 252-257.
Akahoshi M, Yoshimoto G, Nakashima H, Miyake K, Inoue Y, Tanaka Y, Tsukamoto H, Horiuchi T, Otsuka T, Harada M 2004 MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod. Rheumatol. 14: 179-183.
Akama H 2007 Antibody to IL-1 or IL-15. Nippon Rinsho 65: 1227-1230.
Akamizu T, Ozaki S, Hiratani H, Uesugi H, Sobajima J, Hataya Y, Kanamoto N, Saijo M, Hattori Y, Moriyama K, Ohmori K, Nakao K 2002 Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity. Clin. Exp. Immunol. 127: 92-98. *
Akazawa A, Sakaida I, Higaki S, Kubo Y, Uchida K, Okita K 2002 Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J. Gastroenterol. 37: 345-353. *
Akbar SM, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, Masumoto T, Horiike N, Onji M 2001 Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells. Eur. J. Clin. Invest. 31: 639-646. *
Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT 2006 CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 1117-1129. *
Akcurin S, Turkkahraman D, Tysoe C, Ellard S, De Leener A, Vassart G, Costagliola S 2008 A family with a novel TSH receptor activating germline mutation (p.Ala485Val). Eur. J. Pediatr. Jan 4 [Epub ahead of print]. *
Akdis M, Akdis CA 2007 Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 119: 780-791. *
Akerman L, Mimouni D, David M 2005 Intravenous immunoglobulin for treatment of pemphigus. Clin. Rev. Allergy Immunol. 29: 289-294.
Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED 2007 Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum. 57: 837-844. *
Akimoto M, Matsushita K, Suruga Y, Aoki N, Ozaki A, Uozumi K, Tei C, Arima N 2007 Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. J. Rheumatol. 34: 1841-1848.
Akimoto S, Abe M, Ishikawa O, Takagi H, Mori M 2001 HLA-DRB1 and DQB1 genes in anticentromere antibody positive patients with SSc and primary biliary cirrhosis. Ann. Rheum. Dis. 60: 639-640. *
Akimoto S, Ishikawa O, Muro Y, Takagi H, Tamura T, Miyachi Y 1999 Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone. J. Dermatol. 26: 18-22.
Akimoto S, Ishikawa O, Takagi H, Miyachi Y 1998 Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone. J. Gastroenterol. Hepatol. 13: 897-901.
Akimoto T, Kobayashi S, Tamura N, Ohsawa T, Kawano T, Tanaka M, Hashimoto H 2005 Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus. Angiology 56: 601-609.
Akisawa N, Maeda T, Iwasaki S, Onishi S 1997 Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. J. Hepatol. 26: 845-851. *
Akisawa N, Nishimori I, Miyaji E, Iwasaki S, Maeda T, Shimizu H, Sato N, Onishi S 1999 The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients. J. Gastroenterol. 34: 366-371.
Akiyama Y, Suzuki T, Tanaka M, Fujimaki T, Asaoka T, Kobayashi K, Ohno S, Imai F, Matuo H 1997 Primary biliary cirrhosis (PBC)-CREST overlap syndrome complicated with Sjogren's syndrome. Ryumachi. 37: 42-47.
Akiyama Y, Tanaka M, Takeishi M, Adachi D, Mimori A, Suzuki T 2000 Clinical, serological and genetic study in patients with CREST syndrome. Intern. Med. 39: 451-456. *
Akman SA, Arikan C, Sozen G, Ozturk C, Yagci RV 2006 Infliximab treatment of pediatric refractory Crohn's disease: a case report. Turk. J. Gastroenterol. 17: 133-136. *
Akobeng A, Zachos M 2004 Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst. Rev. 1: CD003574. *
Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, Abraham SC 2007 Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin. Gastroenterol. Hepatol. 5: 1282-1290.
Aksamit AJ 2006 Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist 12: 293-298.
Aksoy DY, Agbaht K, Harmanci O, Karadag O, Aytemir K, Sungur A, Onat AM, Apras S, Yildiz BO, Bayraktar M 2008 Autoimmune polyendocrine syndrome with atrial septal defect. Am. J. Med. Sci. 335: 157-159.
Aksoy DY, Gurlek A, Ringkananont U, Weiss RE, Refetoff S 2005 Resistance to thyroid hormone associated with autoimmune thyroid disease in a Turkish family. J. Endocrinol. Invest. 28: 379-383.
Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I 2007 Rituximab-related viral infections in lymphoma patients. Leuk. Lymphoma 48: 1307-1312.
Aksu G, Ozturk C, Kavakli K, Genel F, Kutukculer N 2007 Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin. Rheumatol. 26: 366-370. *
Akutsu N, Sakamoto H, Nakagaki T, Sato H, Matsui T, Kobayashi T, Takamura T, Noto H, Katsuramaki T, Hirata K, Imai K, Shinomura Y 2007 A case of alveolar hydatid disease of the liver for which progression was seen on CT images. Nippon Shokakibyo Gakkai Zasshi 104: 1625-1631.
Al Arfaj AS, Rauf Chowdhary A, Khalil N, Ali R 2007 Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus. Clin. Immunol. 124: 83-89. *
Al Attas RA 2002 How common is celiac disease in Eastern Saudi Arabia? Ann. Saudi Med. 22: 315-319.
Al Hussami O, Godinot C, Monier JM, Trepo C, Monier JC 1986 Demonstration of anti-mitochondria antibodies by ELISA. Comparison with the indirect immunofluorescence technique on organ sections. J. Clin. Lab. Immunol. 21: 195-199.
Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A 2008 Frequency of abnormal thyroid function tests in Kuwaiti arabs with autoimmune diseases. Med. Princ. Pract. 17: 61-65.
Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA 2006 Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J. Hepatol. 45: 575-583. *
al-Hussami O, Godinot C, Monier JM, Trepo C, Monier JC 1988 Use of immunoblotting to characterize the mitochondrial antigens recognized by anti-mitochondrial autoantibodies. J. Immunol. Methods 113: 61-73.
Al-Jabri AA, Al Belushi MS, Nsanze H 2003 Frequency and levels of autoantibodies in healthy adult Omanis. Ann. Saudi Med. 23: 372-375.
Al-Khalidi JA, Czaja AJ 2001 Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. Mayo Clin. Proc. 76: 1237-1252. *
Al-Masri AN, Flemming P, Rodeck B, Melter M, Leonhardt J, Petersen C 2006 Expression of the interferon-induced Mx proteins in biliary atresia. J. Pediatr. Surg. 41: 1139-1143.
Al-Mutawa SA, Hegab SM 2004 Behcet's disease. Clin. Exp. Med. 4: 103-131. *
Al-Osaimi AM, Berg CL 2002 Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Am. J. Gastroenterol. 97: S85. *
al-Quaiz MN, O'Grady JG, Tredger JM, Williams R 1994 Variable effect of ursodeoxycholic acid on cyclosporin absorption after orthotopic liver transplantation. Transpl. Int. 7: 190-194.
Al-toma A, Verbeek WH, Mulder CJ 2007 The management of complicated celiac disease. Dig. Dis. 25: 230-236.
Alabraba EB, Lai V, Boon L, Wigmore SJ, Adams DH, Afford SC 2008 Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion. Hepatology 47: 552-562.
Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD 2006 Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin. Immunol. 120: 310-318. *
Alaedini A, Green PH 2005 Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann. Intern. Med. 142: 289-298. *
Alaedini A, Green PH 2008 Autoantibodies in celiac disease. Autoimmunity 41: 19-26.
Alaedini A, Latov N 2006 Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside. J. Neuroimmunol. 177: 167-172.
Alaedini A, Okamoto H, Briani C, Wollenberg K, Shill HA, Bushara KO, Sander HW, Green PH, Hallett M, Latov N 2007 Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J. Immunol. 178: 6590-6595. *
Alam I, Levenson SD, Ferrell LD, Bass NM 1997 Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig. Dis. Sci. 42: 1295-1301. *
Alam S, Khanna R, Sherwani R, Siraj I 2006 Celiac disease: anti-endomysial antibody versus villous atrophy. Indian J. Gastroenterol. 25: 317-318. *
Alarcon GS, Calvo-Alen J, McGwin G, Uribe AG, Toloza SM, Roseman J, Fernandez M, Fessler BJ, Vila L, Ahn C, Tan FK, Reveille JD 2006 Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann. Rheum. Dis. 65: 1168-1174. *
Alarcon-Segovia D, Fishbein E, Alcala H, Olguin-Palacios E, Estrada-Parra S 1970 The range and specificity of antinuclear antibodies in systemic lupus erythematosus. Clin. Exp. Immunol. 6: 557-571. *
Alarcon-Segovia D, Fishbein E, Betancourt VM 1969 Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid. Clin. Exp. Immunol. 5: 429-437. *
Alard JE, Dueymes M, Youinou P, Jamin C 2007 Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun. Rev. 6: 438-443.
Alawneh K, Ashley C, Carlson JA 2008 Neutrophilic myositis as a manifestation of celiac disease: a case report. Clin. Rheumatol. Jan 8 [Epub ahead of print]. *
Alba A, Planas R, Clemente X, Carrillo J, Ampudia R, Puertas MC, Pastor X, Tolosa E, Pujol-Borrell R, Verdaguer J, Vives-Pi M 2008 Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta. Clin. Exp. Immunol. 151: 467-475. *
Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP 2005 Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54: 987-993. *
Albanopoulos K, Armakolas A, Konstadoulakis MM, Leandros E, Tsiobanou E, Katsaragakis S, Alexiou D, Androulakis G 2000 Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. Am. J. Gastroenterol. 95: 1056-1061. *
Alberio L 2008 Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment. Curr. Opin. Hematol. 15: 456-464.
Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B, Samart�n S, Sanderson IR, Van Loo J, Vas Dias FW, Watzl B 2005 Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 94: 452-481. *
Albers R, Bol M, Bleumink R, Willems AA, Pieters RH 2003 Effects of supplementation with vitamins A, C, and E, selenium, and zinc on immune function in a murine sensitization model. Nutrition 19: 940-946. *
Alberti C 2007 Retroperitoneal fibroses: aetiopathogenesis and taxonomic assessment. Eur. Rev. Med. Pharmacol. Sci. 11: 375-382.
Alberu J, Morales-Buenrostro LE, de Leo C, Vargas-Rojas MI, Marino-Vazquez LA, Crispin JC 2007 A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults. Transpl. Immunol. 18: 166-171.
Alcorta DA, Barnes DA, Dooley MA, Sullivan P, Jonas B, Liu Y, Lionaki S, Reddy CB, Chin H, Dempsey AA, Jennette JC, Falk RJ 2007 Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int. 72: 853-864.
Aldebert D, Masy E, Reumaux D, Lion G, Colombel JF, Duthilleul P 1997 Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease. Dig. Dis. Sci. 42: 2350-2355. *
Aldersley MA, Hamlin PJ, Jones PF, Markham AF, Robinson PA, Howdle PD 2000 No polymorphism in the tissue transglutaminase gene detected in coeliac disease patients. Scand. J. Gastroenterol. 35: 61-63. *
Alderson MR, McGowan P, Baldridge JR, Probst P 2006 TLR4 agonists as immunomodulatory agents. J. Endotoxin Res. 12: 313-319.
Alderuccio F, Toh BH, Barnett AJ, Pedersen JS 1986 Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis. J. Immunol. 137: 1855-1859.
Alehan F, Ozcay F, Erol I, Canan O, Cemil T 2008 Increased risk for coeliac disease in paediatric patients with migraine. Cephalalgia Jul 2 [Epub ahead of print].
Aleksunes LM, Goedken M, Manautou JE 2006 Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury. World J. Gastroenterol. 12: 1937-1940. *
Alenmyr L, Matheu V, Uller L, Greiff L, Malm-Erjefalt M, Ljunggren HG, Persson CG, Korsgren M 2005 Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance. Scand. J. Immunol. 62: 437-444. *
Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G 2005 Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin. Exp. Immunol. 140: 173-180. *
Alessandri C, Bombardieri M, Valesini G 2006 Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv. Clin. Chem. 42: 297-326.
Alessandri C, Priori R, Modesti M, Mancini R, Valesini G 2008 The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis. Clin. Rev. Allergy Immunol. 34: 45-49. *
Alessandri C, Scrivo R, Spinelli FR, Ceccarelli F, Magrini L, Priori R, Valesini G 2007 Autoantibody production in anti-TNF-alpha-treated patients. Ann. N. Y. Acad. Sci. 1110: 319-329.
Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T, Manganelli V, Conti F, Esposti ED, Valesini G 2006 Anti-phospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res. Ther. 8: R180. *
Alessandrini F, Pfister S, Kremmer E, Gerber JK, Ring J, Behrendt H 2004 Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris. J. Invest. Dermatol. 123: 1030-1036. *
Alevizaki M, Mantzou E, Cimponeriu A, Saltiki K, Philippou G, Wiersinga W 2008 The Pro(12)Ala PPARgamma gene polymorphism: possible modifier of the activity and severity of thyroid associated orbitopathy (TAO). Clin. Endocrinol. (Oxf.) Jul 7 [Epub ahead of print].
Alexander GJ, Nouri-Aria KT, Eddleston AL, Williams R 1983 Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease. Lancet 1: 1291-1293.
Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI 2007 Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis. BMC Musculoskelet. Disord. 8: 37. *
Alfaro C, Murillo O, Tirapu I, Azpilicueta A, Huarte E, Arina A, Arribillaga L, Perez-Gracia J, Bendandi M, Prieto J, Lasarte J, Melero I 2006 The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases. An. Sist. Sanit. Navar. 29: 77-96.
Alfaro M, Tapadinhas F, Neves A, Costa Trindade J 2007 Atopy and autoimmunity - a case report. Rev. Port. Pneumol. 13: 729-735.
Ali HY, Abdullah ZA 2008 Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome. J. Immunotoxicol. 5: 173-177.
Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L 2008 Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women? Am. J. Reprod. Immunol. 60: 229-237. *
Alimohammadi M, Bjorklund P, Hallgren A, Pontynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerstrom G, Westin G, Scott HS, Hollander GA, Kampe O 2008 Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N. Engl. J. Med. 358: 1018-1028. *
Alizadeh BZ, Valdigem G, Coenen MJ, Zhernakova A, Franke B, Monsuur A, van Riel PL, Barrera P, Radstake TR, Roep BO, Wijmenga C, Koeleman BP 2007 Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. Hum. Mol. Genet. 16: 2552-2559.
Alkam T, Nitta A, Mizoguchi H, Saito K, Seshima M, Itoh A, Yamada K, Nabeshima T 2008 Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice. Behav. Brain Res. 189: 100-106.
Alkan SS 2004 Monoclonal antibodies: the story of a discovery that revolutionized science and medicine. Nat. Rev. Immunol. 4: 153-156. *
Alkassab F, Gourh P, Tan F, Arnett F, Mayes M 2008 Comment on: an allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis: reply. Rheumatology (Oxford) 47: 557.
Alkassab F, Gourh P, Tan FK, McNearney T, Fischbach M, Ahn C, Arnett FC, Mayes MD 2007 An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) 46: 1248-1251. *
Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, Bonkovsky HL 2006 Autoimmune hepatitis triggered by statins. J. Clin. Gastroenterol. 40: 757-776 ..
Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G 2007 Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204: 253-258. *
Allam R, Anders HJ 2008 The role of innate immunity in autoimmune tissue injury. Curr. Opin. Rheumatol. 20: 538-544.
Allegretti M, Moriconi A, Beccari AR, Di Bitondo R, Bizzarri C, Bertini R, Colotta F 2005 Targeting C5a: recent advances in drug discovery. Curr. Med. Chem. 12: 217-236.
Allen DB, MacDonald MJ, Gottschall JL, Hunter JB 1989 Autoimmune thyroid phenomena are not evidence for human lymphocyte antigen-genetic heterogeneity in insulin-dependent diabetes. Am. J. Med. Genet. 33: 405-408.
Allen KJ, Mifsud NA, Williamson R, Bertolino P, Hardikar W 2008 Cell-mediated rejection results in allograft loss after liver cell transplantation. Liver Transpl. 14: 688-694.
Allen SD, Rawale SV, Whitacre CC, Kaumaya PT 2005 Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade. J. Pept. Res. 65: 591-604. *
Allende LM, Corell A, Madrono A, Gongora R, Rodriguez-Gallego C, Lopez-Goyanes A, Rosal M, Arnaiz-Villena A 1997 Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology 90: 388-396. *
Allenspach K, Bergman PJ, Sauter S, Grone A, Doherr MG, Gaschen F 2006 P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies. J. Comp. Pathol. 134: 1-7. *
Allenspach K, Luckschander N, Styner M, Seibold F, Doherr M, Aeschbach D, Gaschen F 2004 Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. Am. J. Vet. Res. 65: 1279-1283.
Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD 2002 Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J. Leukoc. Biol. 71: 677-685. *
Allez M 2008 Practical use of anti-TNF monoclonal antibodies in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 32: 467-477.
Allina J, Stanca CM, Garber J, Hu B, Sautes-Fridman C, Bach N, Odin JA 2008 Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J. Autoimmun. 30: 238-245.
Allison MC, Poulter LW 1991 Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease. Clin. Exp. Immunol. 85: 504-509. *
Alluwaimi AM 2007 The etiology of Mycobacterium avium subspecies paratuberculosis in Crohn's disease. Saudi Med. J. 28: 1479-1484.
Alm JS, Sanjeevi CB, Miller EN, Dabadghao P, Lilja G, Pershagen G, Blackwell JM, Scheynius A 2002 Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun. 3: 71-77. *
Almallah YZ, Ewen SW, El-Tahir A, Mowat NA, Brunt PW, Sinclair TS, Heys SD, Eremin O 2000 Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J. Clin. Immunol. 20: 68-76. *
Almeida PL, Gandolfi L, Modelli IC, Martins RD, Almeida RC, Pratesi R 2008 Prevalence of celiac disease among first degree relatives of Brazilian celiac patients. Arq. Gastroenterol. 45: 69-72. *
Almeras L, Lefranc D, Drobecq H, De Seze J, Dubucquoi S, Vermersch P, Prin L 2004 New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. Proteomics 4: 2184-2194. *
Almroth G, Axelsson T, Mussener E, Grodzinsky E, Midhagen G, Olcen P 2006 Increased prevalence of anti-gliadin IgA-antibodies with aberrant duodenal histopathological findings in patients with IgA-nephropathy and related disorders. Ups. J. Med. Sci. 111: 339-352.
Alnaqdy A, Al-Maskari M 2005 Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease. Med. Princ. Pract. 14: 209-212.
Alnaqdy A, Al-Maskari M 2007 Levels of cytokines and thyroid autoantibodies in Omani patients with Graves' disease. Br. J. Biomed. Sci. 64: 164-167.
Alonso A, Bignone ML, Brunzini M, Brunzini R 2006 Ocular autoimmune pemphigoid and cyclosporin A. Allergol. Immunopathol. (Madr.) 34: 113-115.
Alonso N, Granada ML, Salinas I, Reverter JL, Flores L, Ojanguren I, Martinez-Caceres EM, Sanmarti A 2007 Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis. Eur. J. Endocrinol. 157: 763-769. *
Alonso-Llamazares J, Gibson LE, Rogers RS 3rd 2007 Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int. J. Dermatol. 46: 910-919. *
Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B 2004 Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291: 1875-1879. *
Alper CA 1995 The human immune response to hepatitis B surface antigen. Exp. Clin. Immunogenet. 12: 171-181.
Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE 2008 Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann. Rheum. Dis. 67: 395-401.
Alric L, Thebault S, Selves J, Peron JM, Mejdoubi S, Fortenfant F, Vinel JP 2007 Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status. Gastroenterol. Clin. Biol. 31: 11-16. *
Alsaeid K, Haider MZ, Sharma PN, Ayoub EM 2006 The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis. Rheumatol. Int. 26: 224-228. *
Alsaeid KM, Haider MZ, al-Awadhi AM, Srivastva BS, Ayoub EM 2003 Role of human leukocyte antigen DRB1*0307 and DRB1*0308 in susceptibility to juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 399-402.
Alsayed A, Gad AM, Abdel-Baset H, Abdel-Fattah A, Ahmed A, Azab A 2008 Excess urinary iodine is associated with autoimmune subclinical hypothyroidism among Egyptian women. Endocr. J. 55: 601-605. *
Altintas A, Cil T, Pasa S, Danis R, Kilinc I, Ayyildiz O, Muftuoglu E 2008 Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience. Minerva Med. 99: 7-14.
Altintas A, Pasa S, Cil T, Bayan K, Gokalp D, Ayyildiz O 2008 Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura. Platelets 19: 252-257.
Altrichter S, Kriehuber E, Moser J, Valenta R, Kopp T, Stingl G 2008 Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J. Invest. Dermatol. 128: 2232-2239. *
Altuntas B, Kansu A, Girgin N 1998 Hepatic damage in gluten sensitive enteropathy. Acta Paediatr. Jpn. 40: 597-599.
Alvarado Y, Xin Yao , Jumper C, Hardwicke F, D'Cunha N, Cobos E 2007 Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature. Clin. Appl. Thromb. Hemost. 13: 443-448.
Alvarez B, Revilla C, Domenech N, Perez C, Martinez P, Alonso F, Ezquerra A, Domiguez J 2008 Expression of Toll-like receptor 2 (TLR2) in porcine leukocyte subsets and tissues. Vet. Res. 39: 13.
Alvarez F 2004 Clinical and diagnostics aspects in children. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 87-88. *
Alvarez-Baron E, Bien CG, Schramm J, Elger CE, Becker AJ, Schoch S 2008 Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res. 80: 93-97.
Alvarez-Pellitero P 2008 Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects. Vet. Immunol. Immunopathol. Aug 3 [Epub ahead of print].
Alvaro D, Metalli VD, Alpini G, Onori P, Franchitto A, Barbaro B, Glaser SS, Francis H, Cantafora A, Blotta I, Attili AF, Gaudio E 2005 The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J. Hepatol. 43: 875-883. *
Alver A, Mentese A, Karahan SC, Erem C, Keha EE, Arikan MK, Eminagaoglu MS, Deger O 2007 Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease. Exp. Clin. Endocrinol. Diabetes 115: 287-291.
Alves C, von Dippe P, Amoui M, Levy D 1993 Bile acid transport into hepatocyte smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations. J. Biol. Chem. 268: 20148-20155. *
Alwawi EA, Mehlis SL, Gordon KB 2008 Treating psoriasis with adalimumab. Ther. Clin. Risk Manag. 4: 345-351.
Aly T, Devendra D, Eisenbarth GS 2005 Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes. Am. J. Ther. 12: 481-490.
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ 2005 Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J. Autoimmun. 25: S40-S45.
Alyamani EJ, Brandt P, Pena JA, Major AM, Fox JG, Suerbaum S, Versalovic J 2007 Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalases. Microbiology 153: 1006-1016. *
Alzahrani AS, Sheef MA 2008 Severe primary hyperparathyroidism masked by asymptomatic celiac disease. Endocr. Pract. 14: 347-350.
Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE 2007 T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718. *
Amagai M 2006 Desmoglein, the target molecule in autoimmunity and infection. Nihon Rinsho Meneki Gakkai Kaishi 29: 325-333.
Amagai M 2008 Pemphigus vulgaris and its active disease mouse model. Curr. Dir. Autoimmun. 10: 167-181.
Amagai M, Ahmed AR, Kitajima Y, Bystryn JC, Milner Y, Gniadecki R, Hertl M, Pincelli C, Fridkis-Hareli M, Aoyama Y, Frusic-Zlotkin M, Muller E, David M, Mimouni D, Vind-Kezunovic D, Michel B, Mahoney M, Grando S 2006 Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'? Exp. Dermatol. 15: 815. *
Amakasu H, Kanno A, Abe M 1993 Multiple myeloma occurring in early stage primary biliary cirrhosis. Tohoku J. Exp. Med. 169: 197-203.
Amano K 2007 Anti-TNF-alpha chimeric antibody (infliximab). Nippon Rinsho 65: 1197-1201.
Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Matsuura E, Coppel RL, Gershwin ME 2005 Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J. Immunol. 174: 5874-5883. *
Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Coppel RL, Gershwin ME 2004 Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J. Immunol. 172: 6444-6452. *
Amante AJ, Ejercito R 2008 Management of highly sensitized patients: Capitol Medical Center experience. Transplant. Proc. 40: 2274-2280.
Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, Cunha TM, Ferreira SH, Cunha FQ, Silva TA, Nicoli JR, Vieira LQ, Souza DG, Teixeira MM 2008 Commensal microbiota is fundamental for the development of inflammatory pain. Proc. Natl. Acad. Sci. U.S.A. 105: 2193-2197. *
Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, Gitter AH, Schulzke JD, Fromm M 2005 Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res. 321: 89-96.
Amati L, Caradonna L, Jirillo E, Caccavo D 1999 Immunological disorders in inflammatory bowel disease and immunotherapeutic implications. Ital. J. Gastroenterol. Hepatol. 31: 313-325.
Amati L, Caradonna L, Leandro G, Magrone T, Minenna M, Faleo G, Pellegrino NM, Jirillo E, Caccavo D 2003 Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effects. Curr. Pharm. Design 9: 1937-1945.
Ambinder EP, Cohen LB, Wolke AM, Field SP, Adelsberg B, Schaffner F, Zaroulis CG 1985 The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis. J. Clin. Apheresis 2: 219-223.
Amcheslavsky A, Bar-Shavit Z 2006 Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. J. Cell. Physiol. 207: 244-250. *
Ameen N, Alexis J, Salas P 2000 Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem. Cell Biol. 114: 69-75. *
Ameen NA, Figueroa Y, Salas PJ 2001 Anomalous apical plasma membrane phenotype in CK8-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia. J. Cell Sci. 114: 563-575. *
Amela I, Cedano J, Querol E 2007 Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach. PLoS ONE 2: e512. *
Amer OT, Abd El-Rahma HA, Sherief LM, Hussein HF, Zeid AF, Abd El-Aziz AM 2004 Role of some viral infections in neonatal cholestasis. Egypt J. Immunol. 11: 149-155.
Amer R, Bamonte G, Forrester JV 2007 Resolution of juvenile idiopathic arthritis-associated uveitis after development of common variable immunodeficiency. Eur. J. Ophthalmol. 17: 666-668.
Amezcua-Guerra LM, Prieto P, Bojalil R, Pineda C, Amigo MC 2006 Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association? J. Rheumatol. 33: 2351-2353.
Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gomez-Garcia L, Vargas A, Bojalil R 2006 Presence of antibodies against cyclic citrullinated peptides (anti-CCP) in patients with rhupus: a cross-sectional study. Arthritis Res. Ther. 8: R144. *
Amin NM 2008 Antiphospholipid syndromes in infectious diseases. Hematol. Oncol. Clin. North Am. 22: 131-143.
Aminkeng F, Van Autreve JE, Koeleman BP, Quartier E, Van Schravendijk C, Gorus FK, Van der Auwera BJ; Belgian Diabetes Registry 2007 TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum. Immunol. 68: 690-697.
Amino N, Kimura M, Tanaka S, Izumi Y, Ikemoto M, Tatsumi KI, Takano T, Hidaka Y 2004 Differential diagnosis of hepatitis: development of new laboratory tests for autoimmune hepatitis and progress in pathophysiology. Rinsho Byori 52: 44-50.
Amirzargar AA, Mohseni N, Shokrgozar MA, Arjang Z, Ahmadi N, Yousefi Behzadi M, Amanzadeh A, Shokri F 2008 HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine. Iran. J. Immunol. 5: 92-99.
Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, Tincani A, Trotta F, Sarzi-Puttini P, Atzeni F 2008 Role of infectious agents in systemic rheumatic diseases. Clin. Exp. Rheumatol. 26: S27-S32.
Amital H, Heilweil M, Ulmansky R, Szafer F, Bar-Tana R, Morel L, Foster MH, Mostoslavsky G, Eilat D, Pizov G, Naparstek Y 2005 Treatment with a laminin-derived peptide suppresses lupus nephritis. J. Immunol. 175: 5516-5523. *
Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF 2006 Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin. Vaccine Immunol. 13: 289-296. *
Ammann RW, Renner EC, Gottstein B, Grimm F, Eckert J, Renner EL; Swiss Echinococcosis Study Group 2004 Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001). J. Hepatol. 41: 551-559.
Amos MD, Bridges AJ 2005 Standards for autoantibody testing; addressing future needs for autoimmune disease and cancer diagnosis. Cancer Biomark. 1: 221-227.
Amoura Z, Haroche J, Piette JC 2008 Systemic lupus erythematosus: future therapeutic avenues. Rev. Med. Interne. 29: 718-724.
Amre DK, Lu SE, Costea F, Seidman EG 2006 Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am. J. Gastroenterol. 101: 645-652. *
Amsaguine-Safir S, Bianchi A, Collet P, Huin-Schohn C, Jeanvoine A, Becuwe P, Kremarik-Bouillaud P, Domenjoud L, Keller JM, Schohn H, Dauca M 2003 Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues. Microsc. Res. Tech. 61: 185-190. *
Amu S, Stromberg K, Bokarewa M, Tarkowski A, Brisslert M 2007 CD25-expressing B-lymphocytes in Rheumatic Diseases. Scand. J. Immunol. 65: 182-191. *
Anand AC, Adya CM 1999 Cytokines and inflammatory bowel disease. Trop. Gastroenterol. 20: 97-106.
Anand AC, Elias E, Neuberger JM 1996 End-stage primary biliary cirrhosis in a first generation migrant south Asian population. Eur. J. Gastroenterol. Hepatol. 8: 663-666.
Anand V, Russell AS, Tsuyuki R, Fedorak R 2008 Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can. J. Gastroenterol. 22: 33-36.
Ananieva O, Nilsson I, Vorobjova T, Uibo R, Wadstrom T 2002 Immune responses to bile-tolerant Helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors. Clin. Diagn. Lab. Immunol. 9: 1160-1164. *
Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G 2002 Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism. J. Rheumatol. 29: 1874-1876.
Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M 2002 TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin. Arthritis Rheum. 31: 396-405. *
Anaya JM, Correa PA, Mantilla RD, Jimenez F, Kuffner T, McNicholl JM 2001 Rheumatoid arthritis in African Colombians from Quibdo. Semin. Arthritis Rheum. 31: 191-198. *
Anaya JM, Mantilla RD, Correa PA 2005 Immunogenetics of primary Sjogren's syndrome in Colombians. Semin. Arthritis Rheum. 34: 735-743. *
Anders HJ, Krug A, Pawar RD 2008 Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus. Eur. J. Immunol. 38: 1795-1799. *
Andersen-Ranberg K, HOier-Madsen M, Wiik A, Jeune B, Hegedus L 2004 High prevalence of autoantibodies among Danish centenarians. Clin. Exp. Immunol. 138: 158-163. *
Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA 2007 Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143. *
Anderson AD, McNaught CE, Jain PK, MacFie J 2004 Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53: 241-245. *
Anderson JR, Goudie RB, Gray K, Stuart-Smith DA 1968 Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin. Exp. Immunol. 3: 107-117. *
Anderson LA, McMillan SA, Watson RG, Monaghan P, Gavin AT, Fox C, Murray LJ 2007 Malignancy and mortality in a population-based cohort of patients with coeliac disease or 'gluten sensitivity'. World J. Gastroenterol. 13: 146-151. *
Anderson MS, Bluestone JA 2005 The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23: 447-485. *
Andersson AK, Feldmann M, Brennan FM 2008 Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis. Scand. J. Immunol. 68: 103-111. *
Andersson AK, Li C, Brennan FM 2008 Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res. Ther. 10: 204.
Andersson U, Erlandsson-Harris H 2004 HMGB1 is a potent trigger of arthritis. J. Intern. Med. 255: 344-350. *
Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ 2002 HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 72: 1084-1091. *
Ando T, Jordan P, Wang Y, Itoh M, Joh T, Sasaki M, Elrod JW, Carpenter A, Jennings MH, Minagar A, Alexander JS 2005 MAdCAM-1 expression and regulation in murine colonic endothelial cells in vitro. Inflamm. Bowel Dis. 11: 258-264. *
Ando T, Langley RR, Wang Y, Jordan PA, Minagar A, Alexander JS, Jennings MH 2007 Inflammatory cytokines induce MAdCAM-1 in murine hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte endothelial adhesion in vitro. BMC Physiol. 7: 10. *
Ando T, Latif R, Davies TF 2007 Antibody-induced modulation of TSH receptor post-translational processing. J. Endocrinol. 195: 179-186. *
Andoh A, Bamba T 2002 Treatment of Crohn's disease by anti-cytokine monoclonal antibodies. Nippon Rinsho 60: 117-122.
Andoh A, Deguchi Y, Inatomi O, Yagi Y, Bamba S, Tsujikawa T, Fujiyama Y 2006 Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncol. Rep. 16: 103-107. *
Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM 1990 Sjogren's syndrome in systemic lupus erythematosus. J. Rheumatol. 17: 201-204.
Andre MF, Piette JC, Kemeny JL, Ninet J, Jego P, Delevaux I, Wechsler B, Weiller PJ, Frances C, Bletry O, Wismans PJ, Rousset H, Colombel JF, Aumaitre O; and the French Study Group on Aseptic Abscesses 2007 Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore) 86: 145-161.
Andre T, Louvet C, de Gramont A 2004 Colon cancer: what is new in 2004? Bull. Cancer 91: 75-80.
Andreakos E, Sacre S, Foxwell BM, Feldmann M 2005 The Toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis. Front. Biosci. 10: 2478-2488.
Andreani ML, Frasca G, Brusco G, Borgnino L, Biagi F, Gasbarrini G, Corazza GR 1996 Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?. Ann. Ital. Med. Int. 11: 254-257.
Andreas K, Luebke C, Haeupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M 2008 Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res. Ther. 10: R9. *
Andren M, Johanneson B, Alarcon-Riquelme ME, Kleinau S 2005 IgG Fc receptor polymorphisms and association with autoimmune disease. Eur. J. Immunol. 35: 3020-3029. *
Andreoli L, Malacarne F, Ceribelli A, Kutschera I, Tincani A 2007 Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. Ann. N. Y. Acad. Sci. 1109: 531-537.
Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, Radice A, Corace C, Sinico RA, Meroni PL, Tincani A 2008 Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? J. Autoimmun. 30: 50-56. *
Andreoli V, Cittadella R, Valentino P, Condino F, La Russa A, Liguori M, Manna I, Spadafora P, Nistico R, Pirritano D, Clodomiro A, Quattrone A 2007 The role of VLA4 polymorphisms in multiple sclerosis: an association study. J. Neuroimmunol. 189: 125-128.
Andresen H, Zarse K, Grotzinger C, Hollidt JM, Ehrentreich-Forster E, Bier FF, Kreuzer OJ 2006 Development of peptide microarrays for epitope mapping of antibodies against the human TSH receptor. J. Immunol. Methods 315: 11-18. *
Andryushkova AA, Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsky GA 2006 Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice. FEBS Lett. 580: 5089-5095. *
Andus T, Stange EF, Hoffler D, Keller-Stanislawski B 2003 Suspected cases of severe side effects after infliximab (Remicade) in Germany. Med. Klin. (Munich) 98: 429-436.
Aneja RK, Tsung A, Sjodin H, Gefter JV, Delude RL, Billiar TR, Fink MP 2008 Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. J. Leukoc. Biol. [Epub ahead of print]. *
Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY 2002 Clinical profile of primary sclerosing cholangitis in Singapore. J. Gastroenterol. Hepatol. 17: 908-913. *
Angulo JM, Sigal LH, Espinoza LR 1998 Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin. Arthritis Rheum. 28: 187-192. *
Angulo P 2002 Use of ursodeoxycholic acid in patients with liver disease. Curr. Gastroenterol. Rep. 4: 37-44.
Angulo P, El-Amin O, Carpenter HA, Lindor KD 2001 Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis. Am. J. Gastroenterol. 96: 3021-3027. *
Angulo P, Lindor KD 1999 Primary biliary cirrhosis and primary sclerosing cholangitis. Clin. Liver Dis. 3: 529-570. *
Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD 2000 Serum autoantibodies in patients with primary sclerosing cholangitis. J. Hepatol. 32: 182-187. *
Angulo S, Llopis M, Antolin M, Gironella M, Sans M, Malagelada JR, Pique JM, Guarner F, Panes J 2006 Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1155-G1162. *
Angyal A, Prechl J, Sarmay G 2007 Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases. Expert Opin. Biol. Ther. 7: 691-704.
Anheim M, Degos B, Echaniz-Laguna A, Fleury M, Grucker M, Tranchant C 2006 Ataxia associated with gluten sensitivity, myth or reality? Rev. Neurol. (Paris) 162: 214-221.
Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, Tarkia M, Westerlund A, He Q, Viander M, Ilonen J, Hinkkanen AE 2007 Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Clin. Exp. Immunol. 150: 285-293. *
Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF 2001 Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am. J. Gastroenterol. 96: 2407-2412. *
Annese V, Lombardi G, Perri F, D'Inca R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A 2005 Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - an IG-IBD study. Am. J. Gastroenterol. 100: 84-92. *
Annese V, Piepoli A, Andriulli A, Napolitano G, Bisceglia L, Zelante L, Gasparini P 1998 Polymorphism of motilin gene in patients with Crohn's disease. Dig. Dis. Sci. 43: 715-719. *
Annese V, Piepoli A, Latiano A, Lombardi G, Napolitano G, Caruso N, Cocchiara E, Accadia L, Perri F, Andriulli A 2005 HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis. Colon Rectum 48: 57-64.
Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A 2004 Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Aliment Pharmacol. Ther. 20: 1143-1152. *
Anolik JH 2007 B cell biology and dysfunction in SLE. Bull. N.Y.U. Hosp. Jt. Dis. 65: 182-186. *
Anolik JH, Aringer M 2005 New treatments for SLE: cell-depleting and anti-cytokine therapies. Best Pract. Res. Clin. Rheumatol. 19: 859-878.
Anomasiri WT, Tovell DR, Tyrrell DL 1990 Paramyxovirus membrane protein enhances antibody production to new antigenic determinants in the actin molecule: a model for virus-induced autoimmunity. J. Virol. 64: 3179-3184. *
Ansari AA 2004 Autoimmunity, anergy, lentiviral immunity and disease. Autoimmun. Rev. 3: 530-540.
Antel J, Bar-Or A 2006 Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J. Neuroimmunol. 180: 3-8.
Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Muller S, Senninger N, Russell J, Jauch J, Bergmann J, Granger DN, Krieglstein CF 2006 Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1131-G1137. *
Anthony A, Sim R, Guillaume JL, Strosberg AD, Dhillon AP, Pounder RE, Wakefield AJ 2000 Beta(beta)3-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells. Aliment. Pharmacol. Ther. 14: 579-585. *
Antigoni M, Xinias I, Theodouli P, Karatza E, Maria F, Panteliadis C, Spiroglou K 2007 Increased prevalence of silent celiac disease among Greek epileptic children. Pediatr. Neurol. 36: 165-169.
Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, Menegatti E, Olivieri I, Puoti M, Palazzi C, Roccatello D, Vergani D, Sarzi-Puttini P, Atzeni F 2008 HCV infection: pathogenesis, clinical manifestations and therapy. Clin. Exp. Rheumatol. 26: S39-S47.
Antonelli A, Sedie AD, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, Bombardieri S, Riente L 2006 High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J. Rheumatol. 33: 2026-2028.
Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J 2006 Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44: 34-43. *
Antonio Olivera M, Zapata L, Kaplan M, Bobadilla J, Corte G, de la Mora G, Uribe M, Cabiedes J, Dehesa M, Kershenobich D 1993 Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies. Rev. Gastroenterol. Mex. 58: 220-222.
Antoniou C, Stefanaki I, Stratigos A, Avgerinou G, Stavropoulos P, Potouridou I, Polidorou D, Moustou AE, Kosmadaki M, Katsambas AD 2007 The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital. Br. J. Dermatol. 156: S12-S16.
Antoniu SA 2006 Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting? Expert Opin. Investig. Drugs 15: 181-184.
Antoniu SA 2007 Treatment options for refractory Wegener's granulomatosis: a role for rituximab? Curr. Opin. Investig. Drugs 8: 927-932.
Antonucci A, Negosanti M, Tabanelli M, Varotti C 2007 Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): five cases. J. Dermatolog. Treat. 18: 178-183.
Antoun J, Goulitquer S, Amet Y, Dreano Y, Salaun JP, Corcos L, Plee-Gautier E 2008 CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis. J. Lipid Res. Jun 19 [Epub ahead of print]. *
Antunes H, Abreu I, Nogueiras A, Sa C, Goncalves C, Cleto P, Garcia F, Alves A, Lemos D 2006 First prevalence of celiac disease in a Portuguese population. Acta Med. Port. 19: 115-120.
Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P 2006 Antibodies to viral citrullinated peptide in rheumatoid arthritis. J. Rheumatol. 33: 647-651.
Anzilotti C, Riente L, Pratesi F, Chimenti D, Sedie AD, Bombardieri S, Migliorini P 2007 IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Rheumatology (Oxford) 46: 1579-1582.
Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S 2004 Liver involvement in primary Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 27: 397-401.
Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME 2006 IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J. Autoimmun. 27: 50-53.
Aoki K, Taniyama M, Nagayama C, Oikawa Y, Shimada A 2006 T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase. Ann. N. Y. Acad. Sci. 1079: 181-185. *
Aoki S, Nakazawa T, Ohara H, Sano H, Nakao H, Joh T, Murase T, Eimoto T, Itoh M 2005 Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology 47: 147-158. *
Aoki V, Millikan RC, Rivitti EA, Hans-Filho G, Eaton DP, Warren SJ, Li N, Hilario-Vargas J, Hoffmann RG, Diaz LA; Cooperative Group for Fogo Selvagem Research 2004 Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J. Investig. Dermatol. Symp. Proc. 9: 34-40. *
Aoki-Ota M, Kinoshita M, Ota T, Tsunoda K, Iwasaki T, Tanaka S, Koyasu S, Nishikawa T, Amagai M 2006 Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model. J. Invest. Dermatol. 126: 105-113. *
Aoyama H, Sakugawa H, Nakasone H, Nakayoshi T, Kinjo A, Tamayose M, Higa H, Uema E, Chinen T, Tomiyama R, Uchima N, Kugai Y, Kinjo F, Saito A, Kinjo M 2002 A rare association of primary biliary cirrhosis and pernicious anemia. J. Gastroenterol. 37: 560-563. *
Apan TZ, Kaygusuz S 2006 Echinococcosis: a possible etiology in psoriatic disease. Dermatology 213: 334-336.
Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las Heras G, Corts J, Navarro S, Mora J, Lopez-Hoyos M, Sabater L, Ferrandez A, Bautista D, Perez-Mateo M, Mery S, Sastre J 2005 Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54: 703-709. *
Apostolopoulos J, Ooi JD, Odobasic D, Holdsworth SR, Kitching AR 2006 The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease. J. Immunol. Methods 308: 167-178. *
Ara J, Mirapeix E, Rodriguez R, Pascual J, Alvarez L, Darnell A 1998 Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis. Med. Clin. (Barc.) 111: 536-568.
Arabzadeh A, Troy TC, Turksen K 2007 Changes in the distribution pattern of claudin tight junction proteins during the progression of mouse skin tumorigenesis. BMC Cancer 7: 196. *
Arad G, Levy R, Hillman D, Kaempfer R 2000 Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat. Med. 6: 414-421. *
Arai M 2008 Is the presence of anti-glutamate receptor antibody positive evidence for "autoimmune" encephalitis? Rinsho Shinkeigaku 48: 211.
Arakaki O, Yamamoto Y, Awazawa R, Nonaka K, Taira K, Asato Y, Hagiwara K, Oyama B, Ishii N, Hashimoto T, Uezato H 2008 Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia. J. Dermatol. 35: 437-446.
Arakawa Y, Amaki S, Miyakawa H, Sakai T, Gotou I, Tanaka N, Moriyama M, Iwasaki A, Sugitani M, Arakawa Y 2004 PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody. J. Gastroenterol. 39: 490-495. *
Araki M, Nozaki Y, Motojima K 2007 Transcriptional regulation of metabolic switching PDK4 gene under various physiological conditions. Yakugaku Zasshi 127: 153-162.
Araki Y, Sugihara H, Hattori T 2006 In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis. Oncol. Rep. 16: 1357-1362. *
Arason GJ 2008 The association of complement with common connective tissue diseases - a review. Laeknabladid. 94: 371-374.
Arason GJ, Kolka R, Hreidarsson AB, Gudjonsson H, Schneider PM, Fry L, Arnason A 2005 Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0. Clin. Exp. Immunol. 140: 572-579. *
Araujo EP, De Souza CT, Ueno M, Cintra DE, Bertolo MB, Carvalheira JB, Saad MJ, Velloso LA 2007 Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology 148: 5991-5997. *
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S 2008 Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes. Pediatr. Diabetes 9: 272-276.
Araujo J, da Silva GA, de Melo FM 2006 Serum prevalence of celiac disease in children and adolescents with type 1 diabetes mellitus. J. Pediatr. (Rio J.) 82: 210-214. *
Araya QM 2006 Improving the management of celiac disease: an urgent challenge. Rev. Med. Chil. 134: 361-364.
Arbour L, Rupps R, Field L, Ross P, Erikson A, Henderson H, Hill W, Yoshida E 2005 Characteristics of primary biliary cirrhosis in British Columbia's First Nations population. Can. J. Gastroenterol. 19: 305-310.
Arcavi M, Orfus G 2006 Prevalence of antinuclear envelope antibodies and their isotypes in sera positive for antinuclear antibodies. Medicina (B. Aires) 66: 327-331.
Archimandritis A, Tjivras M, Tsirantonaki M, Hatzis G, Delladetsima I 1995 Sjogren's syndrome with antimitochondrial antibody-negative primary biliary cirrhosis: a case of autoimmune cholangitis. J. Clin. Gastroenterol. 20: 268-270.
Ardesjo B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kampe O, Ekwall O 2008 Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. J. Autoimmun. 30: 273-282.
Ardesjo B, Portela-Gomes GM, Rorsman F, Gerdin E, Loof L, Grimelius L, Kampe O, Ekwall O 2008 Immunoreactivity against goblet cells in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 14: 652-661.
Ardiles LG, Valderrama G, Moya P, Mezzano SA 1997 Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Clin. Nephrol. 47: 1-5.
Ardizzone S, Puttini PS, Cassinotti A, Porro GB 2008 Extraintestinal manifestations of inflammatory bowel disease. Dig. Liver Dis. 40 Suppl. 2: S253-S259.
Arefanian H, Tredget EB, Rajotte RV, Korbutt GS, Gill RG, Rayat GR 2007 Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice. Cell. Transplant. 16: 787-798.
Arend WP 2002 The mode of action of cytokine inhibitors. J. Rheumatol. Suppl. 65: 16-21.
Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK 2002 Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest. Ophthalmol. Vis. Sci. 43: 1004-1011. *
Argueta JG, Shiota S, Yamaguchi N, Masuhiro Y, Hanazawa S 2006 Induction of Porphyromonas gingivalis GroEL signaling via binding to Toll-like receptors 2 and 4. Oral. Microbiol. Immunol. 21: 245-251. *
Argyropoulos C, Nikiforidis GC, Theodoropoulou M, Adamopoulos P, Boubali S, Georgakopoulos TN, Paliogianni F, Papavassiliou AG, Mouzaki A 2004 Mining microarray data to identify transcription factors expressed in naive resting but not activated T lymphocytes. Genes Immun. 5: 16-25. *
Arias CF, Ballesteros-Tato A, Garcia MI, Martin-Caballero J, Flores JM, Martinez-A C, Balomenos D 2007 p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses. J. Immunol. 178: 2296-2306. *
Arias Vallejo E 1985 Centromere antibody in primary biliary cirrhosis. Rev. Esp. Enferm. Apar. Dig. 68: 428.
Aries PM, Hellmich B, Gross WL 2005 Intravenous immunoglobulin therapy in vasculitis: speculation or evidence? Clin. Rev. Allergy Immunol. 29: 237-246.
Aries PM, Witte T, Lamprecht P 2007 Report on the 34th Meeting of the German Clinical Immunology Workgroup, Frankfurt, 03.-04.11.2006. Z. Rheumatol. 66: 63-64.
Arina A, Murillo O, Dubrot J, Azpilikueta A, Alfaro C, Perez-Gracia JL, Bendandi M, Palencia B, Hervas-Stubbs S, Melero I 2007 Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer. Expert Opin. Biol. Ther. 7: 599-615.
Aringer M, Graninger WB, Steiner G, Smolen JS 2004 Safety and efficacy of tumor necrosis factor blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum. 50: 3161-3169. *
Aringer M, Smolen JS 2008 The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res. Ther. 10: 202.
Aringer M, Smolen JS 2008 Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus. Expert Opin. Drug Saf. 7: 411-419.
Aringer M, Steiner G, Graninger WB, Hofler E, Steiner CW, Smolen JS 2007 Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 56: 274-279. *
Arkfeld DG 2008 The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol. Int. 28: 205-215. *
Armagan O, Uz T, Tascioglu F, Colak O, Oner C, Akgun Y 2005 Serological screening for celiac disease in premenopausal women with idiopathic osteoporosis. Clin. Rheumatol. 24: 239-243. *
Armentano F, Knight T, Makker S, Tramontano A 2006 Induction of covalent binding antibodies. Immunol. Lett. 103: 51-57.
Armstrong AM, Gardiner KR, Kirk SJ, Halliday MI, Rowlands BJ 1997 Tumour necrosis factor and inflammatory bowel disease. Br. J. Surg. 84: 1051-1058.
Armstrong D, Wright S, McVeigh C, Finch M 2006 Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman-Sacks endocarditis: a case for antibiotic prophylaxis? Clin. Rheumatol. 25: 583-584. *
Arnaud-Battandier F, Cerf-Bensussan N, Amsellem R, Schmitz J 1986 Increased HLA-DR expression by enterocytes in children with celiac disease. Gastroenterology 91: 1206-1212.
Arndt T, Meier U, Nauck M, Gressner AM 2006 Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: experience with four independent CDT analysis methods. Clin. Chim. Acta 372: 184-187. *
Arnett FC 2000 Genetic studies of human lupus in families. Int. Rev. Immunol. 19: 297-317.
Arnett FC, Bias WB, McLean RH, Engel M, Duvic M, Goldstein R, Freni-Titulaer L, McKinley TW, Hochberg MC 1990 Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J. Rheumatol. 17: 1029-1035.
Arnett FC, Bias WB, Reveille JD 1989 Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmun. 2: 403-413.
Arnett FC, Hamilton RG, Reveille JD, Bias WB, Harley JB, Reichlin M 1989 Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum. 32: 413-419.
Arnett KL, Adams EJ, Gumperz JE, Darke C, Marsh SG, Gelsthorpe K, Parham P 1995 Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802]. Tissue Antigens 46: 316-321.
Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA 2007 The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25: 21-50.
Arnold ML, Dechant M, Doxiadis II, Spriewald BM 2008 Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates. Tissue Antigens 72: 60-66. *
Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J 2004 Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol. 99: 2376-2384. *
Arnott ID, McDonald D, Williams A, Ghosh S 2001 Clinical use of Infliximab in Crohn's disease: the Edinburgh experience. Aliment. Pharmacol. Ther. 15: 1639-1646. *
Aroeira LS 2006 TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis. Clin. Immunol. 119: 252-260. *
Aronoff DM, Serezani CH, Carstens JK, Marshall T, Gangireddy SR, Peters-Golden M, Reddy RC 2007 Stimulatory effects of peroxisome proliferator-activated receptor-gamma on Fcgamma receptor-mediated phagocytosis by alveolar macrophages. PPAR Res. 2007: 52546. *
Aronoff JS, Korelitz BI, Sohn N, Ky A, Rajapakse R, Weinstein MA, Cohen FS 2000 Anorectal Crohn's disease: surgical and medical management. BioDrugs 13: 95-105.
Aronovich R, Gurwitz D, Kloog Y, Chapman J 2005 Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms. Immunobiology 210: 781-788.
Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N 2004 Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus. Mol. Immunol. 41: 449-456. *
Arranz O, Ara J, Rodriguez R, Quinto L, Font J, Mirapeix E, Darnell A 2001 Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients. Clin. Nephrol. 56: 295-301.
Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA 2006 SLURP-2: a novel cholinergic signaling peptide in human mucocutaneous epithelium. J. Cell. Physiol. 208: 238-245. *
Arruda LK, Santos AB 2005 Immunologic responses to common antigens in helminthic infections and allergic disease. Curr. Opin. Allergy Clin. Immunol. 5: 399-402.
Arslan S, Kav T, Besisik F, Kaymakoglu S, Pinarbasi B, Tozun N, Hamzaoglu HO, Duman D, Ulker A, Parlak E, Palabiyikoglu M, Dokmeci A 2003 Clinical outcome of Crohn's disease treated with infliximab. Hepatogastroenterology 50: 952-956.
Artis D, Humphreys NE, Bancroft AJ, Rothwell NJ, Potten CS, Grencis RK 1999 Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection. J. Exp. Med. 190: 953-962. *
Artlett CM, Black CM, Briggs DC, Stephens C, Welsh KI 1996 DNA allelic alterations within VNTR loci of scleroderma families. Br. J. Rheumatol. 35: 1216-1222. *
Aruna BV, Ben-David H, Sela M, Mozes E 2006 A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis. Immunology 118: 413-424. *
Aruna BV, Sela M, Mozes E 2005 Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells. Proc. Natl. Acad. Sci. U.S.A. 102: 10285-10290. *
Arvieux C, Calmus Y, Gane P, Legendre C, Mariani P, Delelo R, Poupon R, Nordlinger B 1993 Immunogenicity of rat hepatocytes in vivo: effect of cholestasis-induced changes in major histocompatibility complex expression. J. Hepatol. 18: 335-341.
Arzoo K, Sadeghi S, Liebman HA 2002 Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann. Rheum. Dis. 61: 922-924. *
Asahi A, Nishimoto T, Okazaki Y, Suzuki H, Masaoka T, Kawakami Y, Ikeda Y, Kuwana M 2008 Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J. Clin. Invest. 118: 2939-2949. *
Asakura H 2002 Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody. Nippon Rinsho 60: 531-538.
Asakura H, Sugimura K 1995 HLA, antineutrophil cytoplasmic autoantibody, and heterogeneity in ulcerative colitis. Gastroenterology 108: 597-599. *
Asakura H, Sugimura K 1999 Present states of development in new drugs and treatment of inflammatory bowel disease. Nippon Rinsho 57: 2490-2495.
Asakura H, Suzuki A, Ohtsuka K, Hasegawa K, Sugimura K 1999 Gut-associated lymphoid tissues in ulcerative colitis. JPEN J. Parenter. Enteral Nutr. 23: S25-S28.
Asakura H, Yao T, Matsui T, Koganei K, Fukushima T, Takazoe M, Hobara R, Nakano H, Okamura S, Matsueda K, Kashida H, Makiyama K, Hiwatashi N, Kashiwagi K, Hibi T 2001 Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings. J. Gastroenterol. Hepatol. 16: 763-769. *
Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K 2006 Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. J. Invest. Dermatol. 126: 1761-1769. *